相关实验视频
Updated: Jan 12, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
86.2K
胰腺癌中的hypoxamiRs:低氧瘤微环境的主调节者
Pooria Salehi-Sangani1, Amir Hosein Maharati2, Bahareh Payami1
1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Cell biology and toxicology
|October 31, 2025
概括
低氧诱导的microRNAs (HypoxamiRs) 通过改变瘤细胞行为和瘤微环境来驱动胰腺癌的进展和治疗抵抗. 向HypoxamiRs为胰腺癌中抗化学抵抗和免疫逃避提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 胰腺癌 (PC) 呈现出包括化学抵抗和免疫逃避在内的攻击性特征,受到其低氧瘤微环境 (TME) 的显著影响.
- 在PC中纤维化层瘤会恶化缺氧,阻碍血液流动,限制治疗的有效性.
- 缺氧诱导的microRNAs (HypoxamiRs) 是PC进展的关键调节者,影响瘤生存和抵抗.
研究的目的:
- 审查HypoxamiRs在胰腺癌中的多样性作用.
- 探索HypoxamiR与缺氧诱导因子 (HIF) 和非编码RNA (ncRNA) 的相互作用.
- 要突出HypoxamiR参与免疫调节,化学抵抗,EMT,自,血管新生和亡.
主要方法:
- 文献综述侧重于胰腺癌中的HypoxamiRs.
- 通过HIF-1α和HIF-2α对HypoxamiR调节的分析.
- 研究HypoxamiR通过异构体从树皮细胞和免疫细胞转移.
主要成果:
- 低胺基Rs极大地调节瘤细胞通路,促进生存和治疗耐药性.
- 缺氧RRs影响缺氧TME内的免疫和 stromal 细胞,包括纤维细胞,星状细胞,巨细胞和NK细胞.
- 外基因组调解HypoxamiR转移,影响TME中的细胞间通信.
结论:
- 低胺基因在胰腺癌中发挥着多方面的作用,驱动关键的瘤性过程.
- 了解HypoxamiR网络与其他ncRNAs对于破译缺氧驱动的途径至关重要.
- 向HypoxamiRs为开发针对化学抵抗和免疫逃避的新胰腺癌疗法提供了一个有希望的途径.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:23Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K